White House Summit on the Future of COVID-19 Vaccines

The COVID-19 pandemic demonstrates the critical importance of vaccines in saving lives and protecting the economy. Our vaccines continue to protect Americans against serious illness. At the same time, a new generation of vaccines has the potential to better prevent infections and be more broadly effective against future variants. This summit will outline a path towards these innovative, next-generation COVID-19 vaccines, featuring leaders on the cutting-edge of discoveries.

RSVP link: https://pitc.zoomgov.com/webinar/register/WN_8Lx74G-PSYOwmdwfcnQ7AQ

AGENDA: White House Summit on the Future of COVID-19 Vaccines

11:00 AM: Opening Remarks – Featuring White House COVID-19 Response Coordinator Dr. Ashish Jha, Acting Director of the White House Office of Science and Technology Policy Dr. Alondra Nelson, and NIAID Director and Chief Medical Advisor to the President Dr. Anthony Fauci

11:30 AM: Panel on Next Generation Vaccine Design and Manufacturing – Moderated by HHS Assistant Secretary for Preparedness and Response Dawn O’Connell, focused on efforts to accelerate the development and production of more broadly protective COVID-19 vaccines. Featuring panelists:

• Paul Burton, Chief Medical Officer, Moderna
• Mei Mei Hu, Chief Executive Officer, Vaxxinity
• Angela Hwang, Group President, Pfizer Biopharmaceuticals Group
• David Kessler, Chief Science Officer, COVID-19 Response
• Sandeep Reddy, Chief Medical Officer, ImmunityBio

12:20 PM: Break

1:15 PM: Panel on Innovation in Vaccine Delivery – Moderated by Acting Science Advisor to the President Dr. Francis Collins, focused on efforts to move forward innovation in vaccine delivery, including intranasal vaccines, patches, and more stable vaccines, with the potential to make vaccines easier to administer and more accessible. Featuring panelists:

• Biao He, Founder and Chief Executive Officer, CyanVac LLC
• Akiko Iwasaki, Sterling Professor of Immunobiology and Molecular, Cellular, and Developmental Biology, Yale University
• Marty Moore, Founder and Chief Scientific Officer, Meissa Vaccines
• Mark Prausnitz, Chief Scientific Officer, Micron Biomedical
• Michelle Smith, Director, Office of Health Equity & HIV Elimination, Arkansas Department of Health

2:10 PM: Panel on Innovation to Advance Vaccine Equity – Moderated by HHS Assistant Secretary for Global Affairs Loyce Pace, focused on efforts to mobilize both domestically and globally so that no one is left behind in the next stage of our pandemic response. Featuring panelists:

• Richard Hatchett, CEO, Coalition for Epidemic Preparedness Innovations (CEPI)
• Kody Kinsley, Secretary, Department of Health & Human Services, North Carolina
• John Nkengasong, U.S. Global AIDS Coordinator
• Denise Smith, Executive Director, National Association of Community Health Workers

3:05 PM: Closing Remarks – Featuring White House COVID-19 Response Coordinator Dr. Ashish Jha